SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-043434
Filing Date
2021-08-11
Accepted
2021-08-11 16:12:27
Documents
71
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q snse-10q_20210630.htm   iXBRL 10-Q 2011514
2 EX-31.1 snse-ex311_6.htm EX-31.1 19284
3 EX-31.2 snse-ex312_8.htm EX-31.2 19597
4 EX-32.1 snse-ex321_7.htm EX-32.1 9550
  Complete submission text file 0001564590-21-043434.txt   7156021

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA snse-20210630.xsd EX-101.SCH 53921
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE snse-20210630_cal.xml EX-101.CAL 45237
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE snse-20210630_def.xml EX-101.DEF 189396
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE snse-20210630_lab.xml EX-101.LAB 416872
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE snse-20210630_pre.xml EX-101.PRE 323095
10 EXTRACTED XBRL INSTANCE DOCUMENT snse-10q_20210630_htm.xml XML 1172320
Mailing Address 620 PROFESSIONAL DRIVE GAITHERSBURG MD 20879
Business Address 620 PROFESSIONAL DRIVE GAITHERSBURG MD 20879 (240) 243-8000
Sensei Biotherapeutics, Inc. (Filer) CIK: 0001829802 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39980 | Film No.: 211163552
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences